TY - JOUR
T1 - Proceedings of the Eighth Annual Deep Brain Stimulation Think Tank
T2 - Advances in Optogenetics, Ethical Issues Affecting DBS Research, Neuromodulatory Approaches for Depression, Adaptive Neurostimulation, and Emerging DBS Technologies
AU - Vedam-Mai, Vinata
AU - Deisseroth, Karl
AU - Giordano, James
AU - Lazaro-Munoz, Gabriel
AU - Chiong, Winston
AU - Suthana, Nanthia
AU - Langevin, Jean Philippe
AU - Gill, Jay
AU - Goodman, Wayne
AU - Provenza, Nicole R.
AU - Halpern, Casey H.
AU - Shivacharan, Rajat S.
AU - Cunningham, Tricia N.
AU - Sheth, Sameer A.
AU - Pouratian, Nader
AU - Scangos, Katherine W.
AU - Mayberg, Helen S.
AU - Horn, Andreas
AU - Johnson, Kara A.
AU - Butson, Christopher R.
AU - Gilron, Ro’ee
AU - de Hemptinne, Coralie
AU - Wilt, Robert
AU - Yaroshinsky, Maria
AU - Little, Simon
AU - Starr, Philip
AU - Worrell, Greg
AU - Shirvalkar, Prasad
AU - Chang, Edward
AU - Volkmann, Jens
AU - Muthuraman, Muthuraman
AU - Groppa, Sergiu
AU - Kühn, Andrea A.
AU - Li, Luming
AU - Johnson, Matthew
AU - Otto, Kevin J.
AU - Raike, Robert
AU - Goetz, Steve
AU - Wu, Chengyuan
AU - Silburn, Peter
AU - Cheeran, Binith
AU - Pathak, Yagna J.
AU - Malekmohammadi, Mahsa
AU - Gunduz, Aysegul
AU - Wong, Joshua K.
AU - Cernera, Stephanie
AU - Wagle Shukla, Aparna
AU - Ramirez-Zamora, Adolfo
AU - Deeb, Wissam
AU - Patterson, Addie
AU - Foote, Kelly D.
AU - Okun, Michael S.
N1 - Publisher Copyright:
© Copyright © 2021 Vedam-Mai, Deisseroth, Giordano, Lazaro-Munoz, Chiong, Suthana, Langevin, Gill, Goodman, Provenza, Halpern, Shivacharan, Cunningham, Sheth, Pouratian, Scangos, Mayberg, Horn, Johnson, Butson, Gilron, de Hemptinne, Wilt, Yaroshinsky, Little, Starr, Worrell, Shirvalkar, Chang, Volkmann, Muthuraman, Groppa, Kühn, Li, Johnson, Otto, Raike, Goetz, Wu, Silburn, Cheeran, Pathak, Malekmohammadi, Gunduz, Wong, Cernera, Wagle Shukla, Ramirez-Zamora, Deeb, Patterson, Foote and Okun.
PY - 2021/4/19
Y1 - 2021/4/19
N2 - We estimate that 208,000 deep brain stimulation (DBS) devices have been implanted to address neurological and neuropsychiatric disorders worldwide. DBS Think Tank presenters pooled data and determined that DBS expanded in its scope and has been applied to multiple brain disorders in an effort to modulate neural circuitry. The DBS Think Tank was founded in 2012 providing a space where clinicians, engineers, researchers from industry and academia discuss current and emerging DBS technologies and logistical and ethical issues facing the field. The emphasis is on cutting edge research and collaboration aimed to advance the DBS field. The Eighth Annual DBS Think Tank was held virtually on September 1 and 2, 2020 (Zoom Video Communications) due to restrictions related to the COVID-19 pandemic. The meeting focused on advances in: (1) optogenetics as a tool for comprehending neurobiology of diseases and on optogenetically-inspired DBS, (2) cutting edge of emerging DBS technologies, (3) ethical issues affecting DBS research and access to care, (4) neuromodulatory approaches for depression, (5) advancing novel hardware, software and imaging methodologies, (6) use of neurophysiological signals in adaptive neurostimulation, and (7) use of more advanced technologies to improve DBS clinical outcomes. There were 178 attendees who participated in a DBS Think Tank survey, which revealed the expansion of DBS into several indications such as obesity, post-traumatic stress disorder, addiction and Alzheimer’s disease. This proceedings summarizes the advances discussed at the Eighth Annual DBS Think Tank.
AB - We estimate that 208,000 deep brain stimulation (DBS) devices have been implanted to address neurological and neuropsychiatric disorders worldwide. DBS Think Tank presenters pooled data and determined that DBS expanded in its scope and has been applied to multiple brain disorders in an effort to modulate neural circuitry. The DBS Think Tank was founded in 2012 providing a space where clinicians, engineers, researchers from industry and academia discuss current and emerging DBS technologies and logistical and ethical issues facing the field. The emphasis is on cutting edge research and collaboration aimed to advance the DBS field. The Eighth Annual DBS Think Tank was held virtually on September 1 and 2, 2020 (Zoom Video Communications) due to restrictions related to the COVID-19 pandemic. The meeting focused on advances in: (1) optogenetics as a tool for comprehending neurobiology of diseases and on optogenetically-inspired DBS, (2) cutting edge of emerging DBS technologies, (3) ethical issues affecting DBS research and access to care, (4) neuromodulatory approaches for depression, (5) advancing novel hardware, software and imaging methodologies, (6) use of neurophysiological signals in adaptive neurostimulation, and (7) use of more advanced technologies to improve DBS clinical outcomes. There were 178 attendees who participated in a DBS Think Tank survey, which revealed the expansion of DBS into several indications such as obesity, post-traumatic stress disorder, addiction and Alzheimer’s disease. This proceedings summarizes the advances discussed at the Eighth Annual DBS Think Tank.
KW - DBS (deep brain stimulation)
KW - adaptive DBS
KW - neuroethics
KW - neuroimaging
KW - novel hardware
KW - optogenetics
UR - http://www.scopus.com/inward/record.url?scp=85105279727&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105279727&partnerID=8YFLogxK
U2 - 10.3389/fnhum.2021.644593
DO - 10.3389/fnhum.2021.644593
M3 - Article
AN - SCOPUS:85105279727
SN - 1662-5161
VL - 15
JO - Frontiers in Human Neuroscience
JF - Frontiers in Human Neuroscience
M1 - 644593
ER -